A Multicenter, Randomized, Double-Blind, Parallel Group Comparison Study of the Safety and Efficacy of Permethrin Foam, 5% Versus Permethrin Foam, 4% Versus Vehicle in Subjects With Sarcoptes Scabiei
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2017
Price : $35 *
At a glance
- Drugs PF 045 (Primary) ; PF 055 (Primary)
- Indications Scabies
- Focus Therapeutic Use
- Sponsors Renaissance Pharma
- 03 Oct 2016 Status changed from active, no longer recruiting to completed.
- 06 May 2015 Planned End Date changed from 1 Feb 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 06 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.